SCHEMBL19675201

SCHEMBL19675201

COCCOCCn1nc(CO)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
MPO P05164 3/20 0.43
REN P00797 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
GLS O94925 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
SLC16A3 O15427 1/20 0.38
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807490 0.86 REN (0.49) MPORENKDM4CKDM4EALDH1A1
SCHEMBL30860197 0.82 SCN9A (0.48) KMT2AMEN1SMN1; SMN2MPOREN
SCHEMBL15882095 0.80 KDM4C (0.49) KMT2AMEN1RENKDM4CKDM4E
SCHEMBL17324732 0.80 REN (0.44) KMT2AMEN1SMN1; SMN2MPOREN
SCHEMBL8242095 0.79 GLS (0.45) KMT2ASMN1; SMN2MPOKDM4CKDM4E
SCHEMBL17321433 0.77 KDM4E (0.47) RENKDM4CKDM4E
SCHEMBL15882528 0.76 ELANE (0.56) KDM4E
SCHEMBL30860242 0.75 REN (0.39) KMT2AMEN1SMN1; SMN2MPOREN
SCHEMBL13131353 0.74 REN (0.47) MPORENKDM4CKDM4EALDH1A1
SCHEMBL14158232 0.74 NPC1 (0.43) KMT2AMEN1SMN1; SMN2MPOREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed